Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Co-therapy comprising a small molecule CSF-1R inhibitor and an agonistic antibody that specifically binds CD40 for the treatment of cancer

Co-therapy comprising a small molecule CSF-1R inhibitor and an agonistic antibody that specifically binds CD40 for the treatment of cancer

US Patent 10857230 · Granted Dec 8, 2020

Estimated economic value: $82,354,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mounting systems, kits, and methods that provide access to a secondary device on2025
Antibodies binding to vista at acidic pH2024
Immunostimulatory agonistic antibodies for use in treating cancer2023
Antibodies against OX-40 and uses thereof2022
Antibodies against OX40 and uses thereof2020
Agonistic antibodies specifically binding CD40 and methods of use2020
Agonistic antibodies specifically binding CD40 and methods of use2020
Antibodies against OX40 and uses thereof2017
System and method for synchronization of haptic data and media data2016
Polymeric instrument for cleaning canals in endodontic procedures2016
Fundus photographic technique to determine eye refraction for optic disc size ca2005
Emergency telecommunication device2004